EN

The Ensign Group, Inc.

ENSGHealthcareNASDAQ

Medical Care Facilities · Last scanned Oct 26, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$5.06B
+18.7% YoY
Net Income
$344.0M
+15.4% YoY
EBITDA
$567.9M
+18.7% YoY
Free Cash Flow
$280.6M

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 19▼ Below MA1500.5% below MA150
Oct 17▼ Below MA1500.5% below MA150
About The Ensign Group, Inc.

The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. At a $10.23B market cap, The Ensign Group, Inc. ranks as a large-cap company within healthcare. It operates through two segments: Skilled Services and Standard Bearer.

Where ENSG stands vs its 150-day and 200-day moving averages

As of the October 19, 2026 close, ENSG finished 0.54% below its 150-day moving average ($177.59) and 2.66% below its 200-day moving average ($181.46). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is ENSG overbought or oversold?

At the October 19, 2026 close, ENSG's RSI(14) was 50.7, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$10.23B
P/E (TTM)27.52
Fwd P/E20.45
EPS$6.38
Beta0.66
52W Change-5.9%
Dividend Yield0.15%
ROE17.0%
Analysis

The Ensign Group, Inc. carries $2.25B in total debt against $320.8M in cash reserves — debt is roughly 7.0x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow comes in at $280.6M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 17.0% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 5.5% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $3.03B (2022) to $5.06B (2025), reflecting a 67% increase over the period.

With a beta below 0.7, The Ensign Group, Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing ENSG.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms